by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
SAN FRANCISCO and CAMBRIDGE, United Kingdom, Sept. 07, 2016 (GLOBE NEWSWIRE) — Cantabio Pharmaceuticals, Inc. (OTCQB:CTBO) today announced the completion of a licensing agreement with Cambridge Enterprise that gives the company access to intellectual property...
by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
Jim Fickenscher will assume role as Chief Financial Officer, VP, Corporate Development Dr. Nancy Tich appointed VP, Clinical, in a newly created position DEVON, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage...
by GlobeNewsWire | Oct 19, 2015 | Globe Newswire, News Buzz
LAS VEGAS, Oct. 19, 2015 (GLOBE NEWSWIRE) — (OTCQB:VRCI) Verde Science, Inc., is a leading Pharmaceutical Research and Development Company that maintains a strong collaboration with leading scientists and pharma companies to create and test pharmaceutical...
by GlobeNewsWire | Sep 10, 2015 | Globe Newswire
MENLO PARK, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone (rhGH) for growth hormone...
by GlobeNewsWire | Sep 1, 2015 | Globe Newswire
SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced the appointment...